2,2-Dimethylthiopropionamide is used as a reagent to synthesize Dabrafenib, an inhibitor of BRAF kinase that is used to treat BRAF V600-mutation positive carcinoma. BRAF is a gene that mediates cell growth and is activated by mutations caused by cancer. 2,2-Dimethylthiopropionamide is also used as a reagent to prepare sulfonyl-substituted 4,5-diarylthiazoles, compounds that act as cyclooxygenase-2 inhibitors (anti-inflammatory agents).

CAS：630-22-8
中文别名：2,2-二甲基硫代丙胺;
英文别名：2,2-dimethylpropanethioamide;
分子式：C5H11NS
分子量：117.213
精确质量：117.061
Psa：58.11
Logp：2.0189

密度：0.978g/cm3
沸点：162.1ºC at 760 mmHg
熔点：117-119ºC (ethyl acetate hexane )
闪点：51.9ºC
折射率：1.513